Health Catalyst (HCAT) Expected to Announce Quarterly Earnings on Wednesday

Health Catalyst (NASDAQ:HCAT) is projected to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Health Catalyst to post earnings of $0.11 per share and revenue of $79.59 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Health Catalyst Stock Down 3.0 %

HCAT opened at $5.23 on Monday. The business has a 50 day moving average price of $6.24 and a 200 day moving average price of $7.31. Health Catalyst has a twelve month low of $5.20 and a twelve month high of $9.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The firm has a market cap of $318.25 million, a P/E ratio of -3.87 and a beta of 1.34.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Citigroup reduced their target price on Health Catalyst from $10.50 to $10.00 and set a “buy” rating for the company in a report on Friday, January 10th. Stephens boosted their target price on Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a report on Thursday, November 14th. Piper Sandler reduced their target price on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a report on Tuesday, February 11th. KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a report on Wednesday, January 8th. Finally, Canaccord Genuity Group cut their price target on Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a report on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.20.

Insider Activity

In other news, CFO Jason Alger sold 19,599 shares of the business’s stock in a transaction that occurred on Friday, December 6th. The stock was sold at an average price of $8.32, for a total transaction of $163,063.68. Following the sale, the chief financial officer now directly owns 86,712 shares in the company, valued at approximately $721,443.84. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Linda Llewelyn sold 6,442 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $7.88, for a total value of $50,762.96. Following the sale, the insider now owns 98,702 shares in the company, valued at approximately $777,771.76. This represents a 6.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 87,610 shares of company stock worth $664,043. Company insiders own 2.50% of the company’s stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.